CSDX — CS DIAGNOSTICS CORP.
—
·
Materials ·
Chemicals ·
CIK 1106861 ·
Last close
$0.01
Market Cap
$2.12M
52W High
$0.40
52W Low
$0.00
ADV30
6,925
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | -94,200 | — | 39,138 | 39,138 | 499,485,555 | 6,813 | 15,262 |
| Sep 2025 | 23,050 | — | -182 | -182 | 499,431,013 | 13 | 1,609 |
| Dec 2024 | -106,381 | — | -12,687 | -12,687 | 499,400,501 | 501 | 1,428 |
| Sep 2024 | 7,964 | — | 536 | 536 | — | — | — |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-14,191
Investing CF
$499,444,401
Financing CF
$0
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-4,696,710
Inventory
—
Receivables
$31,000
ST Investments
$78,742
EBIT TTM
$26,269
Pretax Income TTM
$26,269
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$204,000
EBITDA
—
Free Cash Flow
$-20,396
Enterprise Value
$7,244,989
Total Cash
$6,813
Total Debt
$0
Shares Out
249,992,200
Trailing EPS
$0.00
Book Value
$2.00
ROE
0.0%
ROA
0.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | 71,219 | 71,219 | 499,485,555 | 15,262 | 499,470,293 | 6,312 |
| Dec 2024 | 0 | 761 | 761 | 499,400,501 | 1,428 | 499,399,073 | 11,031 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BYAH | Park Ha Biological Technology Co., Ltd. | $2.07M | $2.77 | — |
| IMCC | IM Cannabis Corp. | $1.72M | $2.84 | — |
| AKAN | AKANDA CORP. | $1.65M | $3.05 | — |
| HGYN | HONG YUAN HOLDING GROUP | $3.43M | $0.05 | — |
| CYAN | CYANOTECH CORP | $3.55M | $0.49 | — |
News headlines (Yahoo Finance, 1h cache)
CS Group (OTCQB: CSDX) Appoints Shah Teelani & Associates, a Dubai-Based PCAOB Auditor, to Consolidate All 2025 Financial Statements for CSDX, CS Interpharm GT LLC and CS Diagnostics Pharma GmbH
2026-02-11 15:01 · Yahoo
CS Group (OTCQB: CSDX) Secures Strategic Manufacturing Partnerships, Accelerating Global Commercial Launch of MEDUSA SDP Hygiene Products
2026-01-29 13:49 · Yahoo
How Investors Are Reacting To FedEx (FDX) Freight Spin-Off And Shift Toward Higher-Value Logistics Services
2026-01-25 22:06 · Yahoo
CS Diagnostics Picks DHL for MEDUSA SDP Rollout Might Change The Case For Investing In Deutsche Post (XTRA:DHL)
2026-01-25 22:06 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.